Concepedia

Davis Gates

DG

22

Publications

591

Citations

16

H-Index

1972

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Colorado Denver

Vanderbilt University Medical Center

Bayer (Switzerland)

Clinical Research Institute

Davis Gates is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, asthma, and allergy.

Top concepts

Publications per year

1972–2025

22

Publications

22

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol

Georg Griesinger, Davis Gates, Paul Devroey et al. · PLoS ONE · 2016 · 92 citations · Full text

Desloratadine therapy for symptoms associated with perennial allergic rhinitis

Kenneth Kim, Gordon L. Sussman, Jacques Hébert et al. · Annals of Allergy Asthma & Immunology · 2006 · 48 citations

, , +6

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia

Antonio Arrieta, Lillian Sung, John S. Bradley et al. · PLoS ONE · 2019 · 46 citations · Full text

Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol

Luk Rombauts, Cornelis B. Lambalk, A. Schultze-Mosgau et al. · Fertility and Sterility · 2015 · 38 citations · Full text

, , +14

Loratadine versus cetirizine: Assessment of somnolence and motivation during the workday

Luis M. Salmun, Davis Gates, Martin B. Scharf et al. · Clinical Therapeutics · 2000 · 36 citations

, , +3

Rows per page

1–5 of 22